1. Home
  2. BDTX vs EVC Comparison

BDTX vs EVC Comparison

Compare BDTX & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • EVC
  • Stock Information
  • Founded
  • BDTX 2014
  • EVC 1996
  • Country
  • BDTX United States
  • EVC United States
  • Employees
  • BDTX N/A
  • EVC N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • EVC Broadcasting
  • Sector
  • BDTX Health Care
  • EVC Industrials
  • Exchange
  • BDTX Nasdaq
  • EVC Nasdaq
  • Market Cap
  • BDTX 181.4M
  • EVC 188.3M
  • IPO Year
  • BDTX 2020
  • EVC 2000
  • Fundamental
  • Price
  • BDTX $2.93
  • EVC $2.40
  • Analyst Decision
  • BDTX Strong Buy
  • EVC
  • Analyst Count
  • BDTX 6
  • EVC 0
  • Target Price
  • BDTX $14.83
  • EVC N/A
  • AVG Volume (30 Days)
  • BDTX 969.2K
  • EVC 223.6K
  • Earning Date
  • BDTX 08-05-2025
  • EVC 08-05-2025
  • Dividend Yield
  • BDTX N/A
  • EVC 8.44%
  • EPS Growth
  • BDTX N/A
  • EVC N/A
  • EPS
  • BDTX 0.09
  • EVC N/A
  • Revenue
  • BDTX $70,000,000.00
  • EVC $378,623,000.00
  • Revenue This Year
  • BDTX N/A
  • EVC $64.06
  • Revenue Next Year
  • BDTX N/A
  • EVC N/A
  • P/E Ratio
  • BDTX $33.20
  • EVC N/A
  • Revenue Growth
  • BDTX N/A
  • EVC 23.10
  • 52 Week Low
  • BDTX $1.20
  • EVC $1.58
  • 52 Week High
  • BDTX $6.75
  • EVC $2.73
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 56.77
  • EVC 52.87
  • Support Level
  • BDTX $3.02
  • EVC $2.31
  • Resistance Level
  • BDTX $3.28
  • EVC $2.46
  • Average True Range (ATR)
  • BDTX 0.19
  • EVC 0.10
  • MACD
  • BDTX -0.01
  • EVC -0.02
  • Stochastic Oscillator
  • BDTX 53.33
  • EVC 39.39

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: